|
Muz Mansuri is a co-founder of Gilliam Capital and a Senior Advisor to JSB-Partners based in our Boston office. Dr. Mansuri focuses on product and business evaluation of prospective biotech companies. His chemistry expertise and business experience in drug discovery and development are valuable assets to our clients.
Experience
Prior to joining JSB-Partners, Dr. Mansuri was a general partner at Flagship Ventures, where he was responsible for investment activities in the chemistry, drug discovery, drug development, genomics, proteomics and systems biology areas. Previously, he was Executive Vice President and Chief Operating Officer of GPC Biotech in Boston following GPC's acquisition of Mitotix in March 2000. From 1994-2000 Dr. Mansuri was with Mitotix, most recently holding the post of Chief Executive Officer. Before he joined Mitotix, Dr. Mansuri spent nearly ten years at Bristol-Myers Squibb Company in various research positions, culminating in Director, Central Chemistry.
Boards
Dr. Mansuri is a member of the board of directors of CGI Pharmaceuticals (Chairman) and Acretia and is an advisor to Alinea and Resolvyx. He has previously served on the board of directors of AVEO Pharmaceuticals, Adaptive Therapeutics, BG Medicine, and Mitotix Inc.
Education
Dr. Mansuri earned a BS with honors and a PhD in organic chemistry from University College, University of London. He completed postdoctoral fellowships at the University of California, Los Angeles, and Columbia University. | 